MAPP

MAPP or Multi-Antigenic Peptide System is a technique used in biochemistry and immunology to increase the immunogenicity of peptides. The MAPP system involves the synthesis of a peptide with multiple antigenic sites, which can stimulate a stronger immune response than a single antigenic site.

History

The MAPP system was first developed in the 1980s by researchers at the University of California, San Francisco. The technique was initially used to study the immune response to HIV, but has since been applied to a wide range of diseases, including cancer, autoimmune diseases, and infectious diseases.

Method

The MAPP system involves the synthesis of a peptide with multiple antigenic sites. This is achieved by linking several copies of a peptide to a core molecule, creating a branched structure. The resulting multi-antigenic peptide can stimulate a stronger immune response than a single antigenic site.

Applications

The MAPP system has been used in a wide range of applications, including:

• Vaccine development: The MAPP system can be used to create vaccines that stimulate a strong immune response. This has been used in the development of vaccines for diseases such as HIV, hepatitis B, and malaria.

• Immunotherapy: The MAPP system can be used to stimulate the immune system to attack cancer cells. This has been used in the development of immunotherapies for diseases such as melanoma and lung cancer.

• Research: The MAPP system can be used to study the immune response to various diseases. This has been used in research into diseases such as autoimmune diseases, infectious diseases, and cancer.

See also

• Peptide synthesis
• Immunology
• Vaccine development
• Immunotherapy

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia

   This article is a medical stub. You can help WikiMD by expanding it!